ns 2028 has been researched along with Cancer of Prostate in 1 studies
NS 2028: structure in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haramis, G | 1 |
| Zhou, Z | 1 |
| Pyriochou, A | 1 |
| Koutsilieris, M | 1 |
| Roussos, C | 1 |
| Papapetropoulos, A | 1 |
1 other study available for ns 2028 and Cancer of Prostate
| Article | Year |
|---|---|
cGMP-independent anti-tumour actions of the inhibitor of soluble guanylyl cyclase, ODQ, in prostate cancer cell lines.
Topics: Antineoplastic Agents; Caspase 3; Cell Death; Cell Line, Tumor; Cell Movement; Cell Proliferation; C | 2008 |